Literature DB >> 28449344

Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis.

Shintaro Akiyama1, Toshimitsu Fujii1, Katsuyoshi Matsuoka1, Ebana Yusuke2, Mariko Negi3, Kento Takenaka1, Masakazu Nagahori1, Kazuo Ohtsuka1, Mitsuaki Isobe2, Mamoru Watanabe1.   

Abstract

BACKGROUND AND AIM: Takayasu arteritis (TA) is occasionally complicated with inflammatory bowel disease (IBD). This study assessed the endoscopic and genetic features of IBD complicated with TA (IBD-TA).
METHODS: This study retrospectively reviewed the clinical charts of 142 TA patients (14 men and 128 women; median age 48.5 years [range, 18-97 years]). Human lymphocyte antigen (HLA) types and a single-nucleotide polymorphism rs6871626 in the IL12B gene were assessed in 101 and 81 patients with TA, respectively.
RESULTS: Inflammatory bowel disease was diagnosed in 13 (9.2%) of the 142 patients. The endoscopic features of IBD-TA at initial diagnosis (n = 8) showed discontinuous and focal mucosal inflammations (n = 7, 87.5%), and only one case was diagnosed as ulcerative colitis (UC) at the first colonoscopy. In the genetic comparison of HLA class I between TA patients with IBD and those without IBD, HLA-B*52:01 and C*12:02 were more frequent in the IBD-TA group (P = 0.001 and P = 0.009, respectively). Meanwhile, HLA-DRB-1*15:02, DQA-1*01:03, DQB-1*06:01, and DPB-1*09:01 as HLA class II were positively associated with IBD-TA (P = 0.004, P = 0.019, P = 0.019, and P = 0.002, respectively). IL12B rs6871626 did not show an association with IBD-TA compared with that with TA without IBD.
CONCLUSIONS: The endoscopic findings of IBD-TA at initial diagnosis were atypical for UC or Crohn's disease. IBD-TA possessed the HLA haplotype, which had a susceptible effect on UC.
© 2016 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Takayasu arteritis; endoscopic feature; genetic background; inflammatory bowel disease

Mesh:

Substances:

Year:  2017        PMID: 28449344     DOI: 10.1111/jgh.13640

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

Review 1.  Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.

Authors:  Shintaro Akiyama; Soma Fukuda; Joshua M Steinberg; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 2.  Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies.

Authors:  Diana-Maria Bunu; Cristian-Eugen Timofte; Manuela Ciocoiu; Mariana Floria; Claudia-Cristina Tarniceriu; Oana-Bogdana Barboi; Daniela-Maria Tanase
Journal:  Gastroenterol Res Pract       Date:  2019-01-13       Impact factor: 2.260

Review 3.  Takayasu arteritis in an adolescent with Crohn's disease.

Authors:  Lampros Fotis; Afroditi Kourti; Spyridon Prountzos; Efthymia Alexopoulou; Vasiliki Papaevangelou; Smaragdi Fessatou
Journal:  Rheumatol Int       Date:  2021-04-27       Impact factor: 2.631

4.  Changes in Colonic Inflammation Related with Takayasu Arteritis during a 10-year Observation Period.

Authors:  Akinori Wada; Masaaki Higashiyama; Dai Hirata; Suguru Ito; Rina Tanemoto; Shin Nishii; Akinori Mizoguchi; Kenichi Inaba; Nao Sugihara; Yoshinori Hanawa; Kazuki Horiuchi; Yoshihiro Akita; Kazuyuki Narimatsu; Shunsuke Komoto; Kengo Tomita; Ryota Hokari
Journal:  Intern Med       Date:  2021-08-13       Impact factor: 1.271

5.  Takayasu Arteritis Complicated by Ischemic Colitis: A Case Report.

Authors:  Shigeyuki Yamashita; Kanetsugu Nagao; Toshio Doi; Shigeki Yokoyama; Akio Yamashita; Kazuaki Fukahara; Naoki Yoshimura
Journal:  Ann Vasc Dis       Date:  2022-03-25

6.  Coexistence of Takayasu's Arteritis in Patients with Inflammatory Bowel Diseases.

Authors:  Camilla de Almeida Martins; Ana Elisa Rabe Caon; Carolina Bortolozzo Graciolli Facanali; Carlos Walter Sobrado; Sergio Carlos Nahas; Rosa Maria Rodrigues Pereira; Reuma Margalit-Yehuda; Uri Kopylov; Natalia Sousa Freitas Queiroz
Journal:  Gastroenterol Res Pract       Date:  2021-02-12       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.